Authors: Eiselt, R Domanski, TL Zibat, A Mueller, R Presecan-Siedel, E Hustert, E Zanger, UM Brockmoller, J Klenk, HP Meyer, UA Khan, KK He, YA Halpert, JR Wojnowski, L

Citation: R. Eiselt et al., Identification and functional characterization of eight CYP3A4 protein variants, PHARMACOGEN, 11(5), 2001, pp. 447-458

Authors: Gellner, K Eiselt, R Hustert, E Arnold, H Koch, I Haberl, M Deglmann, CJ Burk, O Buntefuss, D Escher, S Bishop, C Koebe, HG Brinkmann, U Klenk, HP Kleine, K Meyer, UA Wojnowski, L

Citation: K. Gellner et al., Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene, PHARMACOGEN, 11(2), 2001, pp. 111-121

Authors: Hustert, E Zibat, A Presecan-Siedel, E Eiselt, R Mueller, R Fuss, C Brehm, I Brinkmann, U Eichelbaum, M Wojnowski, L Burk, O

Citation: E. Hustert et al., Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4, DRUG META D, 29(11), 2001, pp. 1454-1459

Authors: Faiella, A Wernig, M Consalez, GG Hostick, U Hofmann, C Hustert, E Boncinelli, E Balling, R Nadeau, JH

Citation: A. Faiella et al., A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression, HUM MOL GEN, 9(2), 2000, pp. 227-236